Search / 77 posts tagged BMY
Subscribe-
Big Pharma Pipeline: Why So Dry?
http://seekingalpha.com/ article/ 93586-big-pharma-pipeline-why-so-dry?source=fe…Pharmaceutical companies are trading well below their historical P/E levels. To anyone who follows the industry, this comes as no surprise. After a slew of blockbuster drugs that hit the market several years ago, the R&D departments of the largest companies have been coming up empty as of late.
-
Biotech Outlook: M&A Will Continue
http://seekingalpha.com/ article/ 93480-biotech-outlook-m-a-will-continue?source…Checking on the biotechnology sector, we spoke with Zacks senior analyst Grant Zeng, CFA about recent developments among these companies. We discussed M&A [mergers and acquisitions] activity as well as top Buy recommendations. How has earnings season gone this quarter? Any major surprises?
-
Five Biopharma Companies Drop on Negative Drug News
http://seekingalpha.com/ article/ 92996-five-biopharma-companies-drop-on-negativ…Within a 12-hour period five biopharma companies revealed negative drug news that is sending their stocks lower -- in the case of Amylin Pharmaceuticals (AMLN) and Cell Genesys (CEGE), much lower. After the closing bell Tuesday, Bristol-Myers Squibb (BMY) and Pfizer (PFE) announced a bloodclot drug they're working on didn't perform as well as they'd hoped it would in a clinical trial.
-
Before the bell: FNM, FRE, AMLN, BMY, AAPL, AMR …
http://thebusinesstipster.com/ 2008/ 08/ 27/ before-the-bell-fnm-fre-amln-bmy-aa…Before the bell: FNM, FRE, AMLN, BMY, AAPL, AMR … Posted by: in Latest News Filed under: Before the bell, Analyst reports, Analyst upgrades and downgrades, Deals, Microsoft (MSFT), Apple Inc (AAPL), Hewlett-Packard (HPQ), Pfizer (PFE), Bristol-Myers Squibb (BMY), Federal Natl Mtge (FNM),
-
Before the bell: FNM, FRE, AMLN, BMY, AAPL, AMR …
http://lifeandmoneytoday.com/ 2008/ 08/ 27/ before-the-bell-fnm-fre-amln-bmy-aap…Before the bell: FNM, FRE, AMLN, BMY, AAPL, AMR … Posted by: in Housing Filed under: Before the bell, Analyst reports, Analyst upgrades and downgrades, Deals, Microsoft (MSFT), Apple Inc (AAPL), Hewlett-Packard (HPQ), Pfizer (PFE), Bristol-Myers Squibb (BMY), Federal Natl Mtge (FNM), ConocoPhillips
-
The Best Way to Buy Into the Biotech Boom
http://www.contrarianprofits.com/ articles/ the-best-way-to-buy-into-the-biotech…There's a merger boom going on right now, but amid all the gloom, no one's really paying much attention. It could be because the sector in question has had a miserable few years itself, while almost every other industry was partying. But now, at last, after a long stay in the doldrums, the biotech sector is finally coming back into the spotlight.
-
Best Mutual Fund of 2008
http://everydayfinance.blogspot.com/ 2008/ 08/ best-mutual-fund-of-2008.htmlIn considering the best mutual fund of the year 2008 (so far), I concluded that the best risk-adjusted return belongs to an actively managed, focused fund. While I'm a big proponent of low-fee index funds as a base investment, if you're looking to outperform the market, there's no sense in paying
-
Companies With Recent, Innovative Product Approvals vs. Healthcare ETFs
http://seekingalpha.com/ article/ 90988-companies-with-recent-innovative-product…The table below presents a global index of healthcare companies that have received FDA approval for innovative products in the last 12 months. The index excludes all approvals for label expansions of existing products and reformulations of existing products to select only original product approvals -- including drugs, biological agents, and medical devices.
-
Updates on the Healthcare/Biotech Mergers
http://seekingalpha.com/ article/ 90876-updates-on-the-healthcare-biotech-merger…Before I get to my favorite biotech saga, there are noteworthy, if not newsworthy, press releases out this morning from two takeout targets. Genentech (DNA) put out a statement from the special independent board committee that's been appointed to handle the Roche (RHHBY.PK) buyout offer.
-
Icahn’s push for superior ImClone (IMCL) price might backfire
http://thebusinesstipster.com/ 2008/ 08/ 05/ icahns-push-for-better-imclone-imcl…Icahn’s push for superior ImClone (IMCL) price might backfire Posted by: in Latest News Filed under: Deals, Microsoft (MSFT), Yahoo! (YHOO), Bristol-Myers Squibb (BMY), ImClone Systems (IMCL) Bristol-Myers Squibb (NYSE: BMY) has made a $60 a share offer for the part of ImClone (NASDAQ: IMCL) that it does not already own.
Rising and falling
About / rising and falling
Find posts and stories that have something in common using this weighted list of phrases, where popularity is represented by size. Learn more...
Mentions by Day
Posts tagged BMY per day for the past 30 days.
